F Pajonk - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F Pajonk

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 1999

Erythropoietin for patients undergoing radiotherapy: a pilot studyM Henke, R Guttenberger, A Barke, et al.

American Journal of Clinical Oncology|October 5, 2001

Molecular pathways that modify tumor radiation responseM Pervan, F Pajonk, J R Sun, et al.

Current Cancer Drug Targets|January 21, 2011

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 1999

Erythropoietin for patients undergoing radiotherapy: a pilot studyM Henke, R Guttenberger, A Barke, et al.

American Journal of Clinical Oncology|October 5, 2001

Molecular pathways that modify tumor radiation responseM Pervan, F Pajonk, J R Sun, et al.

Current Cancer Drug Targets|January 21, 2011

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.

Pageof 2